Report cover image

Global Biotechnology Reagents Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 07, 2024
Length 160 Pages
SKU # EMAR18558245

Description

Global Biotechnology Reagents Market Report and Forecast 2024-2032


Global Biotechnology Reagents Market Report and Forecast 2024-2032

Global Biotechnology Reagents Market Outlook

The global biotechnology reagents market size was valued at USD 34.1 billion in 2023, driven by shift towards biopharmaceuticals within the healthcare sector across the globe. The market size is anticipated to grow at a CAGR of 8.03% during the forecast period of 2024-2032 to achieve a value of USD 68.4 billion by 2032.

Biotechnology Reagents: Introduction

Biotechnology reagents are essential compounds or substances used in biochemical and molecular biology experiments, diagnostics, and research. These reagents play a critical role in various applications, including DNA sequencing, cloning, gene expression, and protein synthesis analysis. Common types of biotechnology reagents include enzymes, buffers, nucleotides, antibodies, and growth media. Their quality and purity significantly affect the accuracy, reliability, and reproducibility of scientific experiments, making them indispensable in the field of biotechnology for drug discovery, genetic research, and diagnostic testing.

Key Trends in the Global Biotechnology Reagents Market

The biotechnology reagents market is experiencing growth fuelled by the rising demand for personalized medicine. This trend towards customization in healthcare, focusing on individual genetic profiles to tailor treatments, necessitates advanced reagents for precise diagnostics and therapeutic interventions.

There's a significant shift towards biopharmaceuticals within the healthcare sector, driving demand for biotechnology reagents used in drug discovery, development, and manufacturing processes. The production of vaccines, monoclonal antibodies, and other biological products relies heavily on high-quality reagents.

Technological advancements in molecular biology, such as CRISPR, next-generation sequencing, and high-throughput screening, are expanding the applications for biotechnology reagents. These innovations require specialized reagents, contributing to market growth.

Increased investment in R&D activities, particularly in genomics, proteomics, and metabolomics, is driving the need for specialized biotechnology reagents. Academic institutions, research laboratories, and biotech companies are major contributors to this trend.

The growing prevalence of chronic diseases worldwide, including cancer and genetic disorders, has heightened the need for diagnostic and therapeutic biotechnology solutions. This, in turn, boosts the demand for reagents in clinical diagnostics and research.

Regenerative medicine, including stem cell therapy and tissue engineering, is a rapidly evolving field requiring specific biotechnology reagents for cell culture, differentiation, and analysis.

The expansion of point-of-care (POC) testing into more sophisticated molecular diagnostics has created a niche for biotechnology reagents outside traditional laboratory settings, catering to the need for rapid, on-site diagnostic results.

Global Biotechnology Reagents Market Segmentation

Market Breakup by Technology
  • Life Science Reagents
  • PCR
  • Cell Culture
  • Hematology
  • In-vitro Diagnostics
  • Other Technologies
  • Analytical Reagents
  • Chromatography
  • Mass Spectrometry
  • Electrophoresis
  • Flow Cytometry
  • Other Analytical Reagents
Market Breakup by Applications
  • Protein Synthesis and Purification
  • Gene Expression
  • DNA and RNA Analysis
  • Drug Testing
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Biotechnology Reagents Market Overview

In North America, the Biotechnology Reagents market is highly advanced, driven by technological innovation, widespread adoption of electronic health records (EHRs), and significant investments in health IT infrastructure. The region leads in the application of analytics and artificial intelligence (AI) to improve patient care, operational efficiency, and personalized medicine. Regulatory frameworks and initiatives promoting data sharing and privacy protection also shape the market dynamics.

Europe's market benefits from strong healthcare systems, robust data protection regulations like the GDPR, and a focus on research and innovation. There's a growing emphasis on interoperability and the secure exchange of health information across borders, facilitating the use of Big Data for public health monitoring, clinical research, and personalized healthcare. Collaborative projects and funding at the EU level support advancements in health data analytics.

The Asia-Pacific region exhibits rapid growth in the Biotechnology Reagents market, driven by increasing healthcare digitization, rising investments in healthcare infrastructure, and a growing focus on telemedicine and mobile health applications. Countries like China, Japan, and South Korea are investing heavily in AI and machine learning to address healthcare challenges, improve disease surveillance, and enhance patient outcomes. However, the region faces challenges related to data standardization and integration.

Global Biotechnology Reagents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Abbott
  • Agilent Technologies Inc.
  • Danaher
  • BD
  • Bio-Rad Laboratories Inc.
  • General Electric
  • bioMérieux SA
  • LONZA
  • F. Hoffmann-La Roche Ltd.
  • Hoefer, Inc.
  • PerkinElmer Inc.
  • Merck KGaA
  • Promega Corporation
  • Quality Biological
  • Siemens
  • Bio-Techne
  • TAKARA HOLDINGS INC.
  • Sysmex Corporation
  • Tosoh Corporation
  • Olympus Corporation
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

160 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biotechnology Reagents Market Overview
3.1 Global Biotechnology Reagents Market Historical Value (2017-2023)
3.2 Global Biotechnology Reagents Market Forecast Value (2024-2032)
4 Global Biotechnology Reagents Market Landscape
4.1 Global Biotechnology Reagents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Biotechnology Reagents Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Biotechnology Reagents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Biotechnology Reagents Market Segmentation
6.1 Global Biotechnology Reagents Market by Technology
6.1.1 Market Overview
6.1.2 Life Science Reagents
6.1.2.1 PCR
6.1.2.2 Cell Culture
6.1.2.3 Hematology
6.1.2.4 In-vitro Diagnostics
6.1.2.5 Other Technologies
6.1.3 Analytical Reagents
6.1.3.1 Chromatography
6.1.3.2 Mass Spectrometry
6.1.3.3 Electrophoresis
6.1.3.4 Flow Cytometry
6.1.3.5 Other Analytical Reagents
6.2 Global Biotechnology Reagents Market by Applications
6.2.1 Market Overview
6.2.2 Protein Synthesis and Purification
6.2.3 Gene Expression
6.2.4 DNA and RNA Analysis
6.2.5 Drug Testing
6.2.6 Others
6.3 Global Biotechnology Reagents Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Biotechnology Reagents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Biotechnology Reagents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Biotechnology Reagents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Others
10 Latin America Biotechnology Reagents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Biotechnology Reagents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Agilent Technologies Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Danaher
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 BD
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Bio-Rad Laboratories Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 General Electric
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 bioMérieux SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 LONZA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Hoefer, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 PerkinElmer Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Merck KGaA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Promega Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Quality Biological
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 Siemens
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
17.16 Bio-Techne
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisition
17.16.5 Certifications
17.17 TAKARA HOLDINGS INC.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisition
17.17.5 Certifications
17.18 Sysmex Corporation
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisition
17.18.5 Certifications
17.19 Tosoh Corporation
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisition
17.19.5 Certifications
17.20 Olympus Corporation
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisition
17.20.5 Certifications
18 Global Biotechnology Reagents Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us